PENANG, 22 April 2026 – UMediC Group Berhad (“UMC”), through its specialized subsidiary Ateria Medika, has officially cemented its status as a pioneer in the Malaysian neuromodulation market. Following the official launch on 20 April 2026, the Group announced the successful deployment of its PINS Vagus Nerve Stimulation (VNS) therapy at Gleneagles Hospital Penang, marking the device’s first clinical adoption in the country.

As the sole distributor of this advanced technology in Malaysia, UMC is introducing a life-changing solution for patients suffering from *drug-resistant epilepsy*. The PINS VNS system acts as a “pacemaker for the brain,” delivering precise electrical impulses to the vagus nerve to reduce seizure frequency and intensity.

Strategic Highlights:

First-to-Market Advantage: UMC is currently the only provider of PINS VNS technology in Malaysia, positioning the Group as the primary partner for neurology centers nationwide.

Expansion into Private Healthcare: The partnership with Gleneagles Hospital Penang—a key facility under the IHH Healthcare network—serves as a flagship case study for the further rollout of neuromodulation therapies across leading private hospital chains.

Addressing Unmet Needs: Current data indicates that approximately *30% of epilepsy patients* do not respond to traditional anti-epileptic drugs. UMC’s entry into this segment provides a critical third-line treatment option.

Niche Market Leadership: This move aligns with UMC’s broader strategy to diversify its portfolio from medical consumables and manufacturing into high-value, tech-driven medical devices.

Corporate Commentary:

⁠”The successful launch at Gleneagles Hospital Penang is more than just a business update; it is a testament to our commitment to bringing ‘state-of-the-art’ medical solutions to Malaysia. By securing our first hospital for the PINS VNS therapy, we are setting a new standard in epilepsy care and strengthening our footprint in the specialized neurology segment.” ⁠— *Management, UMediC Group Berhad*

More articles here:

Gleneagles Hospital Penang Launches Advanced Epilepsy Services with VNS Therapy

About UMediC Group Berhad:

UMediC Group Berhad (UMC) is a leading Malaysian healthcare company involved in the manufacturing, marketing, and distribution of medical devices and consumables. Through its subsidiary Ateria Medika, the Group focuses on bringing innovative neurological and cardiovascular solutions to the Southeast Asian market.